Typically, their AI product is an explanatory report, written in accessible language, that provides a personalized plan with next steps, like dietary changes, lifestyle modifications, and consultation ...

For the first time, scientists have used a cutting-edge cell therapy called CAR-T to treat a patient with three different ...

CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.

In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...

In December, The Conversation hosted a webinar on AI’s revolutionary role in drug discovery and development. Skolnick has developed AI-based approaches to predict protein structure and function that ...

Record full-year total revenue and AVISE ® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Several years ago, nephrologists attempted a first-of-its-kind effort ...

CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following investor ...

NEWARK, DELAWARE / ACCESS Newswire / February 26, 2026 / The global autoimmune disease testing market is witnessing steady expansion as healthcare systems intensify focus on early diagnosis and ...

Every time Henry publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...